Pancreas and Related Cancers: Emerging Topics in 2023

Friday, June 9, 2023, 9:30 AM - 2:00 PM, Online, Philadelphia, PA


AMA PRA Category 1 Credits™ (4.00 hours), Non-Physician Attendance (4.00 hours), ANCC Contact Hour(s) (4.00 hours), Nursing Pharmacology Credit (2.00 hours), PA Patient Safety and Risk Credit (0.50 hours)

The ultimate goal of this conference is improve the care of patients with pancreatic and related cancers by focusing on improvements to the diagnostic methods, treatment strategies, and supportive care. Through didactic lectures, case based presentations, and lively discussion with expert faculty, participants will review of the latest technologies and procedures and will be able to improve their delivery of care, determine the need for referrals sooner, and achieve better patient outcomes.

 

VIEW AGENDA HERE

1. Assess the current state of pancreatic cancer in the US and the challenges associated with diagnosis, management, and treatment of this disease.
2. Appraise the role of the gastroenterologist in the diagnosis, screening, testing, and management.
3. Evaluate the various noninvasive imaging including CT, MRI, PET, etc.
4. Evaluate the surgical treatment options available and the risks and benefits associated with each.
5. Examine the pathology of pancreas cancer in terms of its specific nomenclature and future progress.
6. Analyze the various neoadjuvant and adjuvant therapies available, and the applications, implications, and outcomes of these treatment strategies.
7. Discuss the current novel treatment strategies for locally advanced pancreatic cancer.
8. Evaluate the significance of tumor registries and cancer fatigue/distress surveys and their application into practice.
9. Describe therapies used in the treatment of pancreatic cancer such as post-resection and radiation.
10. Assess the value of supportive care and emotional support in treating the cancer patient.
11. Describe the molecular underpinnings and drivers of pancreatic cancer.
12. Identify the appropriate imaging studies for the initial evaluation of patients presenting pancreas cancer pathology.
13. Examine the benefits of palliative therapies such as pharmacologic cytotoxicity and alternative treatment methods.
14. Apply relationship-building values and the principles of collaboration to the care for patients with pancreatic cancer.

Registration Rates:

• Healthcare Professionals- $25
• Jefferson Health Faculty/ Staff - Complimentary
• Industry Attendee - $200

Important Deadlines

• Day of registrations will be accepted online
• No refunds will be granted after May 25, 2023. See full refund policy.

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 4.00 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 4.00 nursing contact hours.

Other Healthcare Professionals: This educational activity is designated for 4.00 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Other Credit
Nursing Pharmacology Credit: This educational activity offers 2.00 nursing pharmacology credit. Qualifying sessions are noted on the agenda.

PA Patient Safety and Risk Credit: This education activity offers .50 PA Patient Safety and Risk credit. Qualifying sessions are noted on the agenda.

Successful Completion

To successfully complete this activity, the required evaluation must be completed no later than <Date-45 days after the last date of activity>. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

Cancellation Policy

Requests for refunds must be submitted in writing and received in the Office of CPD two weeks prior to the start date of the course. There will be no refunds after this period.*  Cancellations notified before the two week time frame will incur a 25% administration fee (with a minimum of $20).  Registrants who fail to attend the conference are responsible for the entire fee.  All refunds will be processed after the conference.  The University reserves the right to cancel or postpone this course due to unforeseen circumstances.  In the event of cancellation or postponement, the University will refund registration fees, but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines or travel agencies. 

Submit refund requests to: Office of Continuing Professional Development Sidney Kimmel Medical College Jefferson Alumni Hall 1020 Locust Street, Suite M-5 Philadelphia, PA 19107

Or by email to [email protected]du - please include the activity name in the subject line.

*Registration fees will be refunded less a 15% administration fee to international conference registrants who are unable to secure a travel visa. Registrants must provide proof of visa denial. 

 Jefferson Release Policy

Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy

As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

This year's conference will be a virtual event. Instructions will be emailed to registered participants before the conference.

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

Exhibit opportunities are available for this conference. For more information, please contact Ariel Levine at [email protected]